- Home
- SGMO
SGMO
Sangamo Therapeutics Inc.
as 04-18-2025 1:43pm EST
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | RICHMOND |
| Market Cap: | N/A | IPO Year: | 2000 |
| Target Price: | $5.17 | AVG Volume (30 days): | 11.3M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.30 - $3.18 | Next Earning Date: | 05-08-2025 |
| Revenue: | $57,800,000 | Revenue Growth: | -67.20% |
| Revenue Growth (this year): | 5.81% | Revenue Growth (next year): | 14.19% |
Latest Sangamo Therapeutics Inc. News
SGMO Breaking Stock News: Dive into SGMO Ticker-Specific Updates for Smart Investing
MT Newswires
15 days ago
Sangamo Signs Capsid License Deal With Eli Lilly; Shares Rise After Hours
Business Wire
15 days ago
Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System
MT Newswires
a month ago
Truist Removes Price Target From Sangamo Therapeutics, Keeps Buy Rating; Price Target Had Been $5
Thomson Reuters StreetEvents
a month ago
Q4 2024 Sangamo Therapeutics Inc Earnings Call
GuruFocus.com
a month ago
Sangamo Therapeutics Inc (SGMO) Q4 2024 Earnings Call Highlights: Strategic Advances and ...
Zacks
a month ago
Sangamo Therapeutics (SGMO) Reports Q4 Loss, Misses Revenue Estimates
Associated Press Finance
a month ago
Sangamo: Q4 Earnings Snapshot
Business Wire
a month ago
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
Compare SGMO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SGMO Sangamo Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.